Pfizer recalls Levoxyl
- Recalling company
- Pfizer
- Product
- Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
- Reason
- Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Sep 29, 2026
- Reported
- Oct 28, 2026
- Distribution
- US Nationwide and Puerto Rico
- Status
- Ongoing
- Quantity
- 15,815 100-count bottles
- Lot / codes
- Lot # 24W06, Exp: 11/30/2026
- Company location
- Manhattan, NY
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0052-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0052-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.